Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.09.2022 | Case report

Amphotericin-B liposomal/miltefosine

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lopez Marcos M, et al. Distinct Laboratory and Clinical Features of Secondary Hemophagocytic Lymphohistiocytosis in Pediatric Visceral Leishmaniasis: A Retrospective Analysis of 127 Children in Andalusia, Spain (2004-2019). Pediatric Infectious Disease Journal 40: 525-530, No. 6, 1 Jun 2021. Available from: URL: http://doi.org/10.1097/INF.0000000000003086 Lopez Marcos M, et al. Distinct Laboratory and Clinical Features of Secondary Hemophagocytic Lymphohistiocytosis in Pediatric Visceral Leishmaniasis: A Retrospective Analysis of 127 Children in Andalusia, Spain (2004-2019). Pediatric Infectious Disease Journal 40: 525-530, No. 6, 1 Jun 2021. Available from: URL: http://​doi.​org/​10.​1097/​INF.​0000000000003086​
Metadaten
Titel
Amphotericin-B liposomal/miltefosine
Lack of efficacy: case report
Publikationsdatum
01.09.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-23815-9

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Covid-19-vaccine